These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 30903363)

  • 1. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.
    Bashraheel SS; Kheraldine H; Khalaf S; Moustafa AA
    Biomed Pharmacother; 2023 Jun; 162():114676. PubMed ID: 37037091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
    Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
    Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial targets of metformin-Are they physiologically relevant?
    Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
    Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.
    Nasri H; Baradaran A; Ardalan MR; Mardani S; Momeni A; Rafieian-Kopaei M
    Iran J Kidney Dis; 2013 Nov; 7(6):423-8. PubMed ID: 24241085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and application of metformin in kidney diseases: An update.
    Song A; Zhang C; Meng X
    Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targets of metformin antitumor action.
    Sośnicki S; Kapral M; Węglarz L
    Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines.
    De la Cruz-López KG; Alvarado-Ortiz E; Valencia-González HA; Beltrán-Anaya FO; Zamora-Fuentes JM; Hidalgo-Miranda A; Ortiz-Sánchez E; Espinal-Enríquez J; García-Carrancá A
    BMC Cancer; 2024 Jul; 24(1):853. PubMed ID: 39026155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity.
    Ramachandran S; Anandan V; Kutty VR; Mullasari A; Pillai MR; Kartha CC
    Clin Sci (Lond); 2018 Mar; 132(6):719-738. PubMed ID: 29382697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
    Vona-Davis L; Rose DP
    Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.
    Dutta S; Shah RB; Singhal S; Dutta SB; Bansal S; Sinha S; Haque M
    Drug Des Devel Ther; 2023; 17():1907-1932. PubMed ID: 37397787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
    Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways: preclinical models and clinical trials with metformin in breast cancer.
    Thompson AM
    Clin Cancer Res; 2014 May; 20(10):2508-15. PubMed ID: 24682417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.